Summary To obtain information regarding the growth-inhibitory effect of 1,25-dihydroxyvitamin D3 and its non-calcaemic analogue 22-oxa-1,25-dihydroxyvitamin D3 on pancreatic cancer cell lines, differences in the effects of Gl-phase cell cycle-regulating factors were studied in vitamin D-responsive and non-responsive cell lines. Levels of expression of cyclins (D1, E and A), cyclin-dependent kinases (2 and 4) and cyclin-dependent kinase inhibitors (p21 and p27) were analysed by Western blotting after treatment with these compounds. In the responsive cells (BxPC-3, Hs 700T and SUP-1), our observations were: (1) marked up-regulation of p21 and p27 after 24 h treatment with 10-7 mol 1-' 1,25-dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3; and (2) marked down-regulation of cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors after 7 days' treatment. In non-responsive cells , no such changes were observed.
1,25-Dihydroxyvitamin D3 (calcitriol, 1,25D3) is well known to induce differentiation of leukaemic cells (Abe et al, 1981; Honma et al, 1983 ). This differentiation is linked to exit from the cell cycle at the restriction (R) point in late GI stage, resulting in growth inhi- bition, which suggests a new strategy for cancer therapy (Pardee, 1974) . Antiproliferative effects of 1,25D3 on several types of adenocarcinoma cells have also been reported (Frampton et al, 1983; Eisman et al, 1987; Shabahang et al, 1993; Peehl et al, 1994) . Recently, non-calcaemic and more potent differentiationinducing analogues of vitamin D have been synthesized to facilitate the clinical application of such compounds (Abe et al, 1987 (Abe et al, , 1991 Anzano et al, 1994; Wali et al, 1995) . Among these, 22-oxa-1,25-dihydroxyvitamin D3 OCT) has been shown to have a potent antiproliferative effect on breast cancer cells inoculated into athymic mice without inducing hypercalcaemia (Abe et al, 1991; Abe-Hashimoto, 1993) . Our previous study showed that OCT as well as 1,25D3 inhibited the proliferation of some pancreatic cancer cell lines, which was linked to Giphase cell cycle arrest and cell differentiation (Kawa et al, 1996) . This cellular differentiation is thought to be closely associated with factors regulating the G, phase of the cell cycle (Halevy et al, 1995; Skapek et al, 1995; Parker et al, 1995) , and the cascades of these cell cycle signals may be induced by cyclin-dependent kinase inhibitors (CDKI) such as p16, p21 and p27 (El-Deiry et al, 1993; Gu et al, 1993; Harper et al, 1993; Serrano et al, 1993; Xiong et al, 1993; Polyak et al, 1994 Correspondence to: S Kawa differentiation-inducing activity of vitamin D and the network of cell cycle-regulating agents, such as retinoblastoma (Rb) protein in keratinocyte ) and p21 and/or p27 in leukaemic cell lines (Jiang et al, 1994; Steinman et al, 1994; Liu et al, 1996; Wang et al, 1996) . Therefore, to clarify the precise effects of vitamin D analogues on cell cycle-regulating agents in pancreatic cancer cell lines, we studied the differences in levels of expression of cyclins, CDKs and CDKIs at different times after treatment with two types of pancreatic cancer cell lines, one responsive and one non-responsive to OCT and 1,25D3. Both types of cell lines have sufficient vitamin D receptor contents (Kawa et al, 1996) , and are moderately to well differentiated, both morphologically and biochemically (Vila et al, 1995) .
MATERIALS AND METHODS Chemicals and cells
OCT and 1,25D3 were kindly provided by Chugai Pharmaceutical (Tokyo, Japan) and purchased from Philip Duphar (Amsterdam, The Netherlands) respectively. The details of the synthetic procedures and characteristics of OCT have been described previously Murayama et al, 1986) . Stock solutions of both agents were prepared at a concentration of 1 x 10-3 mol l-1 in 100% ethanol. The final concentration of ethanol in the culture medium did not exceed 0.01%. Five established pancreatic cancer cell lines were studied. BxPC-3, Hs 700T, Hs 766T and Capan-1 were obtained from the American Type Culture Collection (Rockville, MD, USA); SUP-1 was established in our laboratory from the pleural effusion of a patient with pancreatic cancer. All of these cell lines had sufficient vitamin D receptor content as determined by Scatchard analysis in a previous study (BxPC3, 2743; Hs 766T, 1397; Hs 700T, 800; Capan-1, 695; and SUP-1, 670 fmol mg-' DNA-'; Kawa et al, 1996) and were moderately to Santa Cruz), p21 (Clone#70, Transduction Laboratories, KY, USA) and Rb protein (G3-245, Pharmigen, CA, USA) were used.
Growth inhibition assay
After reaching confluency, cells were washed twice with RPMI-1640 medium, trypsinized and plated in 24-well plates at a density of 2 x 103 per well in 1 ml of the same culture medium. OCT or 1,25D3 was added at a concentration of 1 x 10-7 mol 1-1 to the cell cultures on the second day of the experiment, and the cell cultures were re-fed with fresh culture medium containing OCT and 1,25D3 every 3 days. Growth inhibition was determined by measuring 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) absorbance of living cells, when cells with vehicle came close to confluency (Kawa et al, 1996 , containing 5% non-fat milk and 0.02% sodium azide for 1 h, followed by incubation with mouse monoclonal antibodies against human cyclin DI, cyclin E, cyclin A, p21 or Rb protein or rabbit polyclonal antibodies against human PCNA, CDK2, CDK4 or p27 (0.1 jig ml-') in TBST containing 5% non-fat milk. Filters were then incubated with horseradish peroxidase-conjugated rabbit anti-mouse Ig or donkey antirabbit Ig (1:1000; Amersham, Arlington Heights, IL, USA) in TBST containing 2% non-fat milk. The filters were washed several times with TBST between each step. Bound antibody was detected with an enhanced chemiluminescence (ECL) system (Amersham, Bucks, UK) and exposed to radiographic film. The intensity of each band was measured with a CCD image sensor (densitograph AE-6920-MF; Atto, Japan), and the ratio of the band density of the treated group to that of the vehicle group was calculated. The experiments were repeated at least three times to confirm reproducibility.
RESULTS

Growth inhibition assay and flow cytometry
As shown in Figure 1 , significant growth inhibition was observed in three cell lines, BxPC3, Hs 700T and SUP-1, after treatment with 1 x 10-7 mol 1-1 OCT and 1,25D3. OCT showed slightly more potent suppressive effects on BxPC3 and Hs 700T than 1,25D3. Western blot analysis Western blot analysis showed marked increases in p21 and p27 content in responsive cell lines after 24 h treatment.
Representative results for BxPC-3 are shown in Figure 3 . Means ± s.d. of three experiments for densitometry analysis of p21 and p27 are shown in Figure 4 . Concomitant with marked induction of p21 and p27, an increase in the level of the hypophosphorylated form of Rb protein was observed in responsive cells after 24 h treatment, with the change being more prominent with OCT treatment. Representative results for BxPC-3 are shown in Figure 5 .
In both treatment groups marked changes in the cellular contents of PCNA, cyclins and CDKs were not seen after 1 or 3 days (Figure 6 ).
On the seventh day of treatment, when prominent growth inhibition was observed in treated groups, cellular contents of PCNA and other antigens decreased markedly in responsive cells 
DISCUSSION
During the growth inhibition of pancreatic cancer cell lines, the vitamin D analogues OCT and 1,25D3 suppressed the expression of PCNA and blocked the G1/S transition as revealed by flow cytometric analysis. Vitamin D analogues markedly increased the levels of expression of p21 and p27 after 24 h treatment, which was linked to an increase in the hypophosphorylated form of Rb protein. These results suggest that the induction of p21 and p27 is an early event provoked by vitamin D analogues.
Several studies regarding the growth inhibition or the differentiation of leukaemic cell lines by 1,25D3 have been reported (Jiang et al, 1994; Steinman et al, 1994; Zhang et al, 1995; Wang et al, 1996; Liu et al, 1996) . In HL60 cells (promyelocytic leukaemia cell line), the up-regulation of p21 was reported after treatment with 1,25D3 (Jiang et al, 1994; Steinman et al, 1994) , but this association could not be confirmed by others . In contrast, p27 was proposed to be a new candidate for the mediator of 1,25D3 in HL60 cells (Wang et al, 1996) . Furthermore, both p21 and p27 were reported to be transcriptionally induced by 1,25D3 during the differentiation of the myelomonocytic cell line U937 (Liu et al, 1996) . The present study indicated that p21 and p27 play a major role in the growth inhibition of pancreatic cancer cells that respond to vitamin D analogues. p16 is also considered to be a negative regulator of R point control and has been reported to be induced by 1,25D3 in myelomonocytic leukaemic cells (Liu et al, 1996) . Frequent somatic mutations and homozygous deletions were observed in the p16 gene in pancreatic cancer cells as well as the responsive cell line BxPC-3 and non-responsive cell lines Hs766T and Capan-1 (Caldas et al, 1994) . LOH and point mutations were observed in the gene encoding p53, which induces the transcription of p21 gene, in both responsive and non-responsive cells, BxPC-3 and Capan-1 (Caldas et al, 1994) . These results suggest that the growth-inhibitory effects of vitamin D analogues cannot be mediated by p16 or p53. Vitamin D analogues can use normal-acting machinery of p21 and p27 for the GI phase of cell cycle arrest. In non-responsive cells, which have much higher VDR contents than the responsive cell line SUP-I (Kawa et al, 1996) , both OCT and 1,25D3 could not induce such changes, probably because of the defects in negative regulation of vitamin D analogues through VDR.
For cells to proceed through the G1/S transition, GI cyclin/CDK complexes promote the phosphorylation of Rb protein, which releases the transcription factor E2F, resulting in the expression of various genes whose products mediate cell cycle progression. Under these conditions, the levels of G1 cyclin/CDK activities must exceed the threshold of inhibition set by p21 and p27 (Peters, 1994; Peter and Herskowitz, 1994) . Treatment with vitamin D analogues seems to alter the balance of these associations and increase the availability of p21 and p27 to inhibit the G1-cyclin/CDK complex and induce the hypophosphorylation of Rb protein resulting in blockage of the above sequence. In vitamin D-responsive cell lines, elevated levels of p21 and p27 might overcome the activities of GI cyclin/CDK complex, which would in tum block G /S transition and induce exit from cell cycle or growth arrest. Consequently, such suppressive events may result in the overall suppression of metabolism and the down-regulation of cyclins, CDKs and CDKIs observed on the seventh day of treatment.
In conclusion, the present study showed that vitamin D analogues up-regulate p21 and p27 as an early event, which in tum could block the G1/S transition and lead to growth inhibition in responsive pancreatic cancer cell lines.
